a 26 year old woman attended to our hospital with multifocal giant cell tumor in different sites, one in distal end of right radius with aggresive behavior and amputation of the mid forearm and the second in the head of the right humerus with benign and non aggresive clinical appearance.

BACKGROUND Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac joint treated with selective arterial embolization and curretage. METHOD One patient with giant cell tumor involving the sacroiliac joint was treated with selective...

The ubiquity and fascinating nature of animal aggregations are widely recognised. We report here consistent and previously undocumented occurences of aggregations of a giant alien freshwater fish, the Wels catfish (Silurus glanis). Aggregative groups were on average composed of 25 (± 10 SD, ranging from 15 to 44) adults with estimated average total biomass of 651 kg (386 - 1132) and biomass den...

Giant cell tumor (GCT) of bone is an aggressive skeletal tumor characterized by localized bone resorption. MicroRNA-16-5p (miR-16-5p) has been reported to be downregulated in lesions of patients with GCT, but little is known about its role in GCT. To explore the underlying function of miR-16-5p in GCT, we first detected its expression in patients with GCT. The results showed that osteoclast for...

Resently, we treated a 69-year-old patient with squamous cell carcinoma of lung with osteoclast-like giant cells which were similar with the giant cell tumor of bone. The clinical and pathological characteristics of this case were presented, and the literatures were reviewed. The tumor differed histologically from the pleomorphic carcinoma, which occurs most commonly in the lung and showed dive...

PURPOSE Giant-cell tumor of bone (GCTB) is a locally aggressive, benign osteolytic tumor in which bone destruction is mediated by RANK ligand (RANKL). The RANKL inhibitor denosumab is being investigated for treatment of GCTB. We describe histologic analyses of GCTB tumor samples from a phase II study of denosumab in GCTB. EXPERIMENTAL DESIGN Adult patients with recurrent or unresectable GCTB ...

Background: Giant cell tumor of bone is a locally aggressive, rarely metastasizing that accounts for about 5% tumors and generally occurs in patients between 20 45 years old. A driver mutation the histone 3.3 (H3.3) gene H3F3A has been identified as many 96% giant bone. The immunohistochemical expression H3.3 G34 was found 97.8% cases. In present study, we describe our series cases pediatric &l...

26-year-old female with prior anterior cruciate ligament reconstruction developed an enlarging lytic bone lesion around the tibial screw with sequential imaging over the course of one year demonstrating progression of this finding, which was confirmed histologically to be a giant cell tumor of bone. The lesion originated around the postoperative bed, making the diagnosis challenging during the ...